Equity Capital Markets

Company · CIK 1782223

Pyxis Oncology, Inc.

CIK1782223 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedPYXS (Nasdaq)
First annual or quarterly report2021-11-15

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291801
ShelfEffective
 2025-11-262026-10-015
333-298461
ShelfEffective
 2026-08-202026-08-272
333-278282
ShelfEffective
 2024-03-272024-04-032
333-268100
ShelfEffective
 2022-11-012022-11-142
333-259627
IPOFinal prospectus
 2021-09-172021-10-086

Filings

20
FiledFilingRegistrationAccession
2026-10-01424B5Shelf takedown 333-2918010001437749-26-031667
2026-09-29424B5Shelf takedown 333-2918010001437749-26-031480
2026-09-29424B5Shelf takedown 333-2918010001437749-26-031470
2026-08-27EFFECTDeclared effective 333-2984619999999995-26-002786
2026-08-20S-3Shelf registered 333-2984610001193125-26-359246
2025-12-09EFFECTDeclared effective 333-2918019999999995-25-003615
2025-11-26S-3Shelf registered 333-2918010001437749-25-036389
2024-04-03EFFECTDeclared effective 333-2782829999999995-24-000851
2024-03-27S-3Shelf registered 333-2782820001437749-24-009629
2023-08-24EFFECTDeclared effective 333-2725109999999995-23-002487
2023-06-30EFFECTDeclared effective 333-2725109999999995-23-001957
2022-11-14EFFECTDeclared effective 333-2681009999999995-22-003295
2022-11-01S-3Shelf registered 333-2681000001193125-22-275013
2021-10-08424B4Final prospectus 333-2596270001193125-21-295600
2021-10-07EFFECTDeclared effective 333-2596279999999995-21-003820
2021-10-07S-1/AAmendment 333-2596270001193125-21-293655
2021-10-04S-1/AAmendment 333-2596270001193125-21-290298
2021-10-01S-1/AAmendment 333-2596270001193125-21-288350
2021-09-17S-1Registration filed 333-2596270001193125-21-276227
2021-06-21DRSDraft made public 377-050650000950123-21-008029

All filings of this company · CSV